BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19589471)

  • 1. An evaluation of a Medicaid expansion for cancer care: The Breast and Cervical Cancer Prevention and Treatment Act of 2000.
    Lantz PM; Soliman S
    Womens Health Issues; 2009; 19(4):221-31. PubMed ID: 19589471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care.
    Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
    Womens Health Issues; 2010; 20(6):400-5. PubMed ID: 21050999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the Breast and Ccervical Cancer Ttreatment Act on access to screening and treatment in Oklahoma.
    Campbell JE; Thompson DM; Pate AE
    J Okla State Med Assoc; 2014 Jan; 107(1):11-9. PubMed ID: 24683930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Reform, Medicaid Expansions, and Women's Cancer Screening.
    Ku L; Bysshe T; Steinmetz E; Bruen BK
    Womens Health Issues; 2016; 26(3):256-61. PubMed ID: 26926159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State Medicaid expansion decisions and disparities in women's cancer screening.
    Sabik LM; Tarazi WW; Bradley CJ
    Am J Prev Med; 2015 Jan; 48(1):98-103. PubMed ID: 25441234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program.
    Miller JW; Hanson V; Johnson GD; Royalty JE; Richardson LC
    Cancer; 2014 Aug; 120 Suppl 16(0 16):2549-56. PubMed ID: 25099897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis.
    Albright BB; Nasioudis D; Craig S; Moss HA; Latif NA; Ko EM; Haggerty AF
    Am J Obstet Gynecol; 2021 Feb; 224(2):195.e1-195.e17. PubMed ID: 32777264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for providing follow-up and treatment services in the National Breast and Cervical Cancer Early Detection Program--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(11):215-8. PubMed ID: 9551882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the Breast and Cervical Cancer Prevention and Treatment Act on Medicaid disenrollment.
    Chien LN; Adams EK
    Womens Health Issues; 2010; 20(4):266-71. PubMed ID: 20627776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program.
    Benard VB; Howe W; Royalty J; Helsel W; Kammerer W; Richardson LC
    J Womens Health (Larchmt); 2012 Jul; 21(7):776-82. PubMed ID: 22506920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer treatment experiences by race and location in Georgia's Women's Health Medicaid Program.
    Johnston EM; Blake SC; Andes KL; Chien LN; Adams EK
    Womens Health Issues; 2014; 24(2):e219-29. PubMed ID: 24560120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000.
    Adams EK; Breen N; Joski PJ
    Cancer; 2007 Jan; 109(2 Suppl):348-58. PubMed ID: 17136766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The eligibility and reach of the national breast and cervical cancer early detection program after implementation of the affordable care act.
    Tangka F; Kenny K; Miller J; Howard DH
    Cancer Causes Control; 2020 May; 31(5):473-489. PubMed ID: 32157463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
    Trogdon JG; Ekwueme DU; Subramanian S; Miller JW; Wong FL
    Cancer Causes Control; 2019 Aug; 30(8):813-818. PubMed ID: 31187351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: a collaborative effort among government agencies.
    French C; True S; McIntyre R; Sciulli M; Maloy KA
    Public Health Rep; 2004; 119(3):279-85. PubMed ID: 15158107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lasting Effects of the Breast and Cervical Cancer Early Detection Program on Breast Cancer Detection and Outcomes, Ohio, 2000-2009.
    Koroukian SM; Bakaki PM; Han X; Schluchter M; Owusu C; Cooper GS; Flocke SA
    Prev Chronic Dis; 2015 Jul; 12():E116. PubMed ID: 26203814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Breast and Cervical Cancer Prevention and Treatment Act in Georgia: effects on time to Medicaid enrollment.
    Adams EK; Chien LN; Florence CS; Raskind-Hood C
    Cancer; 2009 Mar; 115(6):1300-9. PubMed ID: 19189369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care reform and women's insurance coverage for breast and cervical cancer screening.
    Levy AR; Bruen BK; Ku L
    Prev Chronic Dis; 2012; 9():E159. PubMed ID: 23098646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Cancer Screening for Low-income Adults Under the Affordable Care Act Medicaid Expansion.
    Hendryx M; Luo J
    Med Care; 2018 Nov; 56(11):944-949. PubMed ID: 30199428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.